Skip to main content
TipRanks
Go Ultimate75% OFF

Solvonis Therapeutics (SVNS) Financial Statements

14 Followers

Solvonis Therapeutics Financial Overview

Solvonis Therapeutics's market cap is currently £7.11M. The company's EPS TTM is £0.00; its P/E ratio is -1.10; Solvonis Therapeutics has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue£ 0.00£ 0.00£ 587.00K£ 542.00K£ 219.00K
Gross Profit£ 0.00£ 0.00£ -134.00K£ -51.00K£ 55.00K
Operating Income£ -3.48M£ -1.38M£ -2.21M£ -2.71M£ -845.00K
EBITDA£ -5.74M£ -1.38M£ -2.94M£ -2.59M£ -900.00K
Net Income£ -5.74M£ -1.59M£ -3.12M£ -2.71M£ -954.00K
Balance Sheet
Cash & Short-Term Investments£ 1.72M£ 757.00K£ 155.00K£ 1.64M£ 598.00K
Total Assets£ 7.58M£ 3.20M£ 2.43M£ 4.94M£ 3.13M
Total Debt£ 75.00K£ 0.00£ 34.00K£ 22.00K£ 950.00K
Net Debt£ -1.65M£ -757.00K£ -121.00K£ -1.62M£ 352.00K
Total Liabilities£ 1.39M£ 119.00K£ 408.00K£ 385.00K£ 2.32M
Stockholders' Equity£ 6.19M£ 3.08M£ 2.03M£ 4.55M£ 812.00K
Cash Flow
Free Cash Flow£ -3.27M£ -1.13M£ -1.47M£ -3.08M£ -255.00K
Operating Cash Flow£ -3.27M£ -1.13M£ -1.24M£ -2.36M£ -254.00K
Investing Cash Flow£ 0.00£ -337.00K£ -232.00K£ -718.00K£ -1.00K
Financing Cash Flow£ 4.23M£ 2.08M£ 0.00£ 4.13M£ 800.00K

Currency in GBP

Solvonis Therapeutics Earnings and Revenue History

-8M-4M04M-3000 %-2000 %-1000 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

Solvonis Therapeutics Liabilities to Assets

03M6M9M0 %30 %60 %90 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Solvonis Therapeutics Cash Flow

-4M-2M02M4M6M201720182019202020212022202320242025OperatingInvestingFinancing

Solvonis Therapeutics Forecast EPS vs Actual EPS

00000000Q2 24Q4 24Q2 25Q4 25Q2 26Q4 26EPS EstimateBeatMiss